• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Single Sperm Freezing System Achieves 87 Percent Recovery in Multicenter Study

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Single Sperm Freezing System Achieves 87 Percent Recovery in Multicenter Study

Single Sperm Freezing System Achieves 87 Percent Recovery in Multicenter Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multicenter retrospective study tracking single-sperm cryopreservation using the Cryopiece carrier system across five reproductive centers in China found an 87.27 percent post-thaw recovery rate and a 52.73 percent clinical pregnancy rate per embryo transfer. Published in the European Journal of Medical Research, the findings evaluate the clinical performance of freezing extremely small numbers of spermatozoa for couples undergoing intracytoplasmic sperm injection. Across 3,394 cryopreserved sperm cells analyzed in the dataset, post-thaw motility reached 55.57 percent, while the overall fertilization rate stood at 72.98 percent among 1,751 inseminations.

Single-sperm cryopreservation offers a clinical pathway for individuals diagnosed with severe oligospermia or azoospermia, allowing the preservation of sparse sperm samples for assisted reproductive technology. Earlier research established the general feasibility of the technique, but existing evidence remained constrained by single-center experimental designs, small patient cohorts, and unresolved questions regarding carrier performance. Because multiple carrier devices have been introduced over time, researchers sought to clarify the generalizability, practical handling, and clinical efficiency of the Cryopiece platform when deployed across diverse reproductive facilities.

To evaluate multicenter outcomes under routine conditions, investigators gathered assisted reproductive technology treatment records from five Chinese fertility centers between January 1, 2015, and May 31, 2025. The investigation focused on couples who received intracytoplasmic sperm injection specifically for male factor infertility over that ten-year interval. Participating clinics adhered to identical data forms, with trained local personnel collecting clinical details at each coordinating site before transmitting the information electronically to the central research group for unified compilation and analysis.

Laboratory measurements demonstrated consistent post-thaw retrieval, recovering 2,962 intact spermatozoa from the 3,394 cryopreserved cells, corresponding to an 87.27 percent recovery rate. Among recovered specimens, 1,646 sperm cells retained active motility, reflecting a post-thaw motility rate of 55.57 percent. When applied in clinical insemination procedures, these cells achieved normal two-pronuclei fertilization in 1,106 of 1,751 oocytes, yielding a 2PN fertilization rate of 63.16 percent alongside the 72.98 percent total fertilization rate observed across the entire multicenter cohort.

Clinical downstream outcomes encompassed 146 embryo transfer cycles, resulting in 77 confirmed clinical pregnancies, which established a pregnancy rate of 52.73 percent per transfer procedure. The delivery rate across these transfers reached 26.03 percent. In multivariable logistic regression modeling aimed at identifying factors influencing pregnancy success, the high-quality embryo rate was the only variable independently associated with achieving a clinical pregnancy, recording an odds ratio of 1.28 with a 95 percent confidence interval from 1.07 to 1.53 (P = 0.008).

Sperm origin introduced notable statistical differences across recovery, motility, and fertilization benchmarks. Epididymal spermatozoa demonstrated significantly higher post-thaw recovery (92.28 percent) and motility (63.50 percent) than either ejaculated sperm (87.03 percent recovery, 57.29 percent motility) or testicular sperm (86.49 percent recovery, 51.18 percent motility), with all pairwise comparisons reaching statistical significance (P < 0.05). Conversely, epididymal spermatozoa exhibited a fertilization rate of 64.49 percent, which was significantly lower than the 75.16 percent achieved with ejaculated sperm and the 71.96 percent observed with testicular sperm (P = 0.012).

The investigation also highlighted the impact of assisted oocyte activation when using thawed motile spermatozoa. Cycles incorporating assisted oocyte activation demonstrated a significantly higher two-pronuclei fertilization rate compared to standard handling (68.13 percent versus 58.80 percent, P < 0.01) and elevated the proportion of high-quality embryos (41.90 percent versus 28.78 percent, P < 0.01). Although the authors concluded that the Cryopiece system provides a reliable carrier for preserving limited sperm quantities, they noted that future prospective studies featuring standardized protocols and extended long-term follow-up remain necessary to confirm these multicenter retrospective findings.

Subject of Research: Clinical efficacy of the Cryopiece system for single-sperm cryopreservation in male factor infertility

Article Title: Effective single-sperm cryopreservation using the cryopiece system in China: a multi-center cohort study

Article References: Huang, C., Jiang, L.-Y., Wang, R.-X., Chen, W., Xiong, Q., Liu, F., Bai, F.-R., Ma, L.-H., Zhu, W.-B., Xue, S.-G., Yao, Y.-L., He, X.-J., & Li, Z. (2026). Effective single-sperm cryopreservation using the cryopiece system in China: a multi-center cohort study. European Journal of Medical Research. https://doi.org/10.1186/s40001-026-05511-5

Image Credits: AI Generated

DOI: 10.1186/s40001-026-05511-5

Keywords: single-sperm cryopreservation, Cryopiece system, intracytoplasmic sperm injection, male factor infertility, oligospermia, azoospermia, post-thaw sperm motility, sperm recovery rate, fertilization rate, clinical pregnancy rate, embryo transfer, assisted oocyte activation, epididymal spermatozoa, testicular spermatozoa, multicenter cohort study, high-quality embryo rate

News Source: Ophelia Keating. (November 17, 2026). Single Sperm Freezing System Achieves 87 Percent Recovery in Multicenter Study. Scienmag.

Tags: assisted oocyte activationazoospermiaclinical pregnancy rateCryopiece systemembryo transferepididymal spermatozoafertilization ratehigh-quality embryo rateintracytoplasmic sperm injectionmale factor infertilityMulticenter Cohort Studyoligospermiapost-thaw sperm motilitysingle-sperm cryopreservationsperm recovery ratetesticular spermatozoa
Share12Tweet7Share2ShareShareShare1

Related Posts

Ropeginterferon Alfa-2b Controls Polycythemia Vera and Cuts Phlebotomy Needs in Practice

Ropeginterferon Alfa-2b Controls Polycythemia Vera and Cuts Phlebotomy Needs in Practice

November 17, 2026
Ontario Centralized Waiting List Linked to Higher Primary Care Attachment Rates

Ontario Centralized Waiting List Linked to Higher Primary Care Attachment Rates

November 17, 2026

Free Farrowing Shortened Farrowing Duration on One Farm Without Increasing Piglet Mortality

November 17, 2026

Over a Third of Older Wrist Fracture Patients Lack Osteoporosis Treatment

November 17, 2026

POPULAR NEWS

  • Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    29 shares
    Share 12 Tweet 7
  • Self-Assessed Hirsutism Accurately Flags Endocrine and Metabolic Disruptions in Oligomenorrheic Women

    29 shares
    Share 12 Tweet 7
  • Genomic Radiosensitivity Metrics Fail to Predict Survival in Canine Sinonasal Tumors

    29 shares
    Share 12 Tweet 7
  • Global Review Highlights Escalating Burden and Care Deficits for Migraine Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pooled Stem Cell Microglia Reveal Genetic Regulators Driving Neurodegenerative Disease Risk

Ropeginterferon Alfa-2b Controls Polycythemia Vera and Cuts Phlebotomy Needs in Practice

Ontario Centralized Waiting List Linked to Higher Primary Care Attachment Rates

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.